This chapter explores the potential of manufacturing drugs in space, discussing examples such as the development of a protein-based artificial retina and the formulation of cancer drugs. It highlights the advantages of microgravity in facilitating the production of complex molecules and the interest of pharmaceutical companies in conducting experiments in space. The challenges and regulatory unknowns surrounding space-based drug manufacturing are also discussed.
Waze Co-Founder Uri Levine explains how the Israel-Hamas war is impacting the Israeli tech industry. Bloomberg Businessweek Editor Joel Weber and Bloomberg News Health Care Reporter Robert Langreth share the details of the Businessweek Magazine story Drug Companies Explore Making Most Lucrative Drugs in Space. And we Drive to the Close with Aaron Kennon, CEO at Clear Harbor Asset Management.
Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.
See omnystudio.com/listener for privacy information.